Clin2
NCT07716800Possibly a fitNot yet recruiting

Thinking and memory in older women with ovarian cancer

Ovarian CancerCognitive DeclineDelirium

Part of Brain & nervous system, Cancer, Hormones & metabolism, Mental health, Women’s health & pregnancy clinical trials.

This study looks at how cancer and its treatment might affect thinking, memory, and confusion in women aged 70 and older with ovarian cancer. The goal is to understand who is at higher risk, so doctors can provide better care and support.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
205 people
Ages
70 years and older
Study type
Observational

Who can take part

  • You are a woman with ovarian cancer.
  • You are 70 years old or older.
  • You have either just been diagnosed with ovarian cancer (any stage) or it has come back for the first time.
  • You have not yet started any cancer treatment or had a major procedure for this cancer.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07125209Recruiting
Chemotherapy and thinking for ovarian cancer

This study looks at how chemotherapy given before surgery for ovarian cancer may affect thinking and memory. It helps doctors understand the cognitive side effects of treatment so they can better support patients.

Madison, Wisconsin
NCT03451383Recruiting
Study brain changes in older breast cancer patients

This study follows older women with newly diagnosed breast cancer to see who might develop thinking or memory problems over time. It may help researchers understand early brain risk and how treatment and other factors relate to cognitive decline.

Washington D.C., District of Columbia
NCT05810701Recruiting
Geriatric screening for newly diagnosed ovarian cancer patients

This study looks at older adults with newly diagnosed epithelial ovarian cancer and checks health factors that can affect treatment, like day-to-day function and support needs. It may help doctors choose better care plans for older patients by understanding risks and needs early.

Odense, Region of South Denmark
NCT04520139Recruiting· Phase 1/Phase 2
NAC to help prevent chemo brain fog in ovarian cancer

This Phase 1/2 study tests whether taking NAC (a supplement medicine) can help prevent or reduce memory and thinking problems after platinum chemotherapy. It targets people with advanced ovarian, fallopian tube, or primary peritoneal cancer who are starting at least six cycles of platinum-based treatment.

Orange, California
NCT07220512Recruiting
Exercise help for ovarian, fallopian, or endometrial cancer

This trial tests a special exercise program during chemotherapy before surgery. It may help patients with certain gynecologic cancers get stronger and better prepared for treatment.

Winston-Salem, North Carolina
NCT05014399Recruiting
Study memory changes during chemotherapy for colorectal cancer

This study looks at cognitive (thinking and memory) changes in people with colorectal cancer who start certain chemotherapy drugs. It aims to understand how treatment affects the brain and may guide better monitoring or support during care.

Fort Wayne, Indiana

Hear when a new Ovarian cancer trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.